PMID: 2099167Jan 1, 1990Paper

Ligament injuries of the upper ankle joint: 10 years experience with a stable shoe

Zeitschrift für Unfallchirurgie und Versicherungsmedizin : offizielles Organ der Schweizerischen Gesellschaft für Unfallmedizin und Berufskrankheiten = Revue de traumatologie et d'assicurologie : organe officiel de la Société suisse de médecine des accide
R Spring

Abstract

To avoid cast fixation after injuries of the ankle ligaments, in 1980 we presented a new high top sports-boot with stabilizing plastic sticks on both sides of the shoe as a new method of after treatment; The original Stabil-S shoe. The follow up after 5 and 10 years experience shows good results and cast immobilisation of the ankle joint is practically not used any more for the above mentioned indication. Patients go back to work after 25 days on an average which is about 3 weeks earlier then with cast immobilisation. This is the reason why insurance companies in Europe cover the costs for this kind of after treatment, the Stabil-S shoe. To verify the fibular ligament lesions we use stressed x-ray examination in addition to the clinical tests and the patients history. The indication of operative or conservative treatment is still discussed. The late results however show better stability and function after operative treatment, especially for the group of young and active sport patients. The further development of the Stabil-S shoe will try to obtain a normal gait as well as sufficient stability around the ankle joint. This means mobility for the patient and stability around the ankle joint.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.